Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
Public ClinicalTrials.gov record NCT04472494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Randomized, Double-Blind Placebo Controlled Study of Intravenous Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
Study identification
- NCT ID
- NCT04472494
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 61 participants
Conditions and interventions
Conditions
Interventions
- Abatacept Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 13, 2020
- Primary completion
- Aug 11, 2021
- Completion
- Sep 12, 2021
- Last update posted
- Oct 6, 2022
2020 – 2021
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alternative Research Associates, Llc | Hialeah | Florida | 33012 | — |
| Alternative Research Associates | Hialeah | Florida | 33012 | — |
| Norton Infectious Disease Institute | Louisville | Kentucky | 40202 | — |
| Boston Childrens Hospital | Boston | Massachusetts | 02115 | — |
| Local Institution - 0002 | Boston | Massachusetts | 02215 | — |
| Atlantic Health System | Morristown | New Jersey | 07960 | — |
| Methodist Health System Clinical Research Institute (MHSCRI) | Dallas | Texas | 75203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04472494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04472494 live on ClinicalTrials.gov.